DE69938501D1 - Verwendung von prohibitin-rns in krebsbehandlung - Google Patents

Verwendung von prohibitin-rns in krebsbehandlung

Info

Publication number
DE69938501D1
DE69938501D1 DE69938501T DE69938501T DE69938501D1 DE 69938501 D1 DE69938501 D1 DE 69938501D1 DE 69938501 T DE69938501 T DE 69938501T DE 69938501 T DE69938501 T DE 69938501T DE 69938501 D1 DE69938501 D1 DE 69938501D1
Authority
DE
Germany
Prior art keywords
prohibitin
rna
utr
portions
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69938501T
Other languages
English (en)
Inventor
Eldon R Jupe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Original Assignee
Oklahoma Medical Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oklahoma Medical Research Foundation filed Critical Oklahoma Medical Research Foundation
Application granted granted Critical
Publication of DE69938501D1 publication Critical patent/DE69938501D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69938501T 1998-07-24 1999-07-24 Verwendung von prohibitin-rns in krebsbehandlung Expired - Lifetime DE69938501D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9397798P 1998-07-24 1998-07-24
PCT/US1999/016840 WO2000005359A1 (en) 1998-07-24 1999-07-24 Use of prohibitin rna in treatment of cancer

Publications (1)

Publication Number Publication Date
DE69938501D1 true DE69938501D1 (de) 2008-05-21

Family

ID=22242037

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69938501T Expired - Lifetime DE69938501D1 (de) 1998-07-24 1999-07-24 Verwendung von prohibitin-rns in krebsbehandlung

Country Status (6)

Country Link
EP (1) EP1100892B1 (de)
JP (1) JP2002522014A (de)
AT (1) ATE391777T1 (de)
CA (1) CA2336595A1 (de)
DE (1) DE69938501D1 (de)
WO (1) WO2000005359A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776310B2 (en) 2000-11-16 2010-08-17 Microspherix Llc Flexible and/or elastic brachytherapy seed or strand
WO2006032528A1 (en) * 2004-09-23 2006-03-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Prohibitin as target for cancer therapy
US20090258020A1 (en) * 2008-01-07 2009-10-15 Patrys Limited Antibody designated barb3, barb3 related antibodies, and methods of making and using same
WO2021058145A1 (en) * 2019-09-24 2021-04-01 Max-Delbrück-Centrum Für Molekulare Medizin In Der Helmholtz-Gemeinschaft Phage t7 promoters for boosting in vitro transcription

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658792A (en) * 1990-11-14 1997-08-19 The United States Of America As Represented By The Department Of Health And Human Services Antiproliferative protein
US5922852A (en) * 1995-06-07 1999-07-13 Oklahoma Medical Research Foundation 3' untranslated region of the human prohibitin gene
US6355427B1 (en) * 1996-11-07 2002-03-12 Oklahoma Medical Research Foundation Diagnostic assay for breast cancer susceptibility

Also Published As

Publication number Publication date
JP2002522014A (ja) 2002-07-23
EP1100892B1 (de) 2008-04-09
ATE391777T1 (de) 2008-04-15
CA2336595A1 (en) 2000-02-03
EP1100892A1 (de) 2001-05-23
WO2000005359A1 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
NO20014058L (no) TRPM-2-antisense-terapi
EP1325019A4 (de) Antisense-modulation der clusterinexpression
ATE334657T1 (de) Hemmung der bcl-2 protein expression durch liposomale antisense-oligodeoxynukleotide
EP1165594A4 (de) Antisens oligonucleotide-modulierung der stat3 expression
WO2005030121A3 (en) Compounds, compositions and methods
DE69431164T2 (de) Gegenläufige oligonukleotide mit hemmender wirkung auf tumorbildung
DK0928335T3 (da) Fremgangsmåde til anvendelse af oligonukleotider med modificerede CpG-dinukleosider
FI973467A0 (fi) DNA-molekyylejä, valmistus ja käyttö geeniterapiassa
EP1190099A4 (de) Antisense-modulierung der p13k p85 expression
MX9804009A (es) Inhibicion de crecimiento tumoral por oligonucleotidos de antisentido para il-8 y receptor de il-8.
WO2002036743A3 (en) Antisense modulation of calreticulin expression
DE60038011D1 (de) Verbesserung der immunantwort als anwendung in impfstoff und gentherapie
MX2008014100A (es) Compuestos y metodos para modular la expresion de pcsk9.
BR0008788A (pt) Sequencias anti-sentido antitumor dirigidas contra componentes r1 e r2 de ribonucleotìdeo reductase
WO2001032832A3 (en) Antisense inhibition of nucleolin expression
EP1123414A4 (de) Antisense modulation der expression von integrin alpha 4
JP2006503904A5 (de)
ATE307886T1 (de) Nukleotidsequenzen, proteine, medikamente und diagnoseagentien zur anwendung in krebsbehandlung
ATE465261T1 (de) Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken
EP1190040A4 (de) Herpes-simplex virus, das fremde gene exprimiert, und ein verfahren, um damit krebs zu behandeln
IL121272A0 (en) Nucleotide comprising compositions and their use for improving therapeutic index of a therapeutic drug
WO2003105755A3 (en) ANTISENSE MODULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION
ATE391777T1 (de) Verwendung von prohibitin-rns in krebsbehandlung
WO2003104397A3 (en) ANTISENSE MODULATION OF PROTEIN KINASE GR 6 EXPRESSION
AU2180501A (en) Novel DNA polymerase inhibitors, mikanolide and dihydromikanolide

Legal Events

Date Code Title Description
8332 No legal effect for de